News
Tempus AI (TEM) Raises 2025 Earnings Guidance Amid US$500 Million Equity Offering
Tempus AI (TEM) has recently been in the spotlight after raising its earnings guidance and reporting a substantial improvement in its financial results for Q2 2025, with revenue jumping from a year ago and a significant reduction in net losses.
16hon MSN
In conjunction with its better-than-expected sales growth in the second quarter, Tempus AI raised its sales outlook for this ...
Yahoo Finance anchor Julie Hyman tracks Friday's top moving stocks and biggest market stories in this Market Minute. Gold ...
TipRanks on MSN18h
TEM Earnings: Tempus AI Stock (TEM) ‘Hitting its Stride’ on Soaring AI Drug DemandShares in health technology group Tempus AI ($TEM) raced 7% higher today after its Q2 revenues surged on cancer testing ...
3don MSN
Although shares have retreated from their all-time high, those who bought shares one year ago are still looking at growth in ...
Analysts expect the Chicago, Illinois-based company to report a quarterly loss at 25 cents per share, versus a year-ago loss ...
In trading on the Nasdaq stock market as of 1:17 p.m. Central, Tempus' stock price was trading at $60.65, up 3.2% from the ...
Tempus Ai (NASDAQ: TEM) stock is seeing an explosive valuation surge in Tuesday's trading thanks to a pair of catalysts. The healthcare software company's share price was up 35.8% as of 3:15 p.m ...
Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback